Bruker BRKR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bsi Biospin | $197.5M-26.0% | $267M+27.9% | $208.7M+6.9% | $195.3M-6.0% | $207.8M-23.7% | |
| Bsi Calid | $316.3M-4.6% | $331.6M+6.0% | $312.7M+9.4% | $285.8M+2.0% | $280.1M-12.6% | |
| Bsi Nano | $246M-20.4% | $309.1M+16.0% | $266.5M+5.7% | $252.1M-1.8% | $256.6M-19.4% | |
| Energy And Supercon Technologies | $66.8M-6.6% | $71.5M-3.1% | $73.8M+11.3% | $66.3M+11.8% | $59.3M-17.8% | |
| Cost Of Segment Revenue by Business | ||||||
| Bsi Biospin | $102.7M-25.0% | $136.9M+23.1% | $111.2M+2.9% | $108.1M-1.5% | $109.7M-11.7% | |
| Bsi Calid | $139.3M-7.8% | $151.1M+15.6% | $130.7M+4.1% | $125.6M+6.6% | $117.8M-14.8% | |
| Bsi Nano | $120.2M-20.3% | $150.8M+17.2% | $128.7M+2.5% | $125.6M+5.6% | $118.9M-20.4% | |
| Energy And Supercon Technologies | $52.5M-11.5% | $59.3M-2.0% | $60.5M+15.7% | $52.3M+12.7% | $46.4M-19.2% | |
| Operating Income by Business | ||||||
| Adjustments And Reconciling Items | $74.1M— | —— | —— | —— | $70M— | |
| Bsi Biospin | $28.8M-54.3% | $63M+89.2% | $33.3M+44.2% | $23.1M-37.7% | $37.1M-52.8% | |
| Bsi Calid | $62.6M-12.7% | $71.7M-5.7% | $76M+42.6% | $53.3M-13.3% | $61.5M-21.2% | |
| Bsi Nano | $14.4M-68.1% | $45.1M+91.9% | $23.5M+150% | $9.4M-59.3% | $23.1M-47.6% | |
| Energy And Supercon Technologies | $7.6M+38.2% | $5.5M-21.4% | $7M-2.8% | $7.2M+2.9% | $7M-18.6% | |
| Selling General And Administrative Expense by Business | ||||||
| Bsi Biospin | $41.8M+0.7% | $41.5M+0.5% | $41.3M+1.0% | $40.9M+4.9% | $39M-11.2% | |
| Bsi Calid | $81.3M+5.2% | $77.3M+2.1% | $75.7M-1.6% | $76.9M+5.5% | $72.9M-1.0% | |
| Bsi Nano | $68.5M-4.6% | $71.8M+2.3% | $70.2M-3.4% | $72.7M+4.9% | $69.3M-12.9% | |
| Energy And Supercon Technologies | $5.9M+3.5% | $5.7M+1.8% | $5.6M-1.8% | $5.7M+7.5% | $5.3M+1.9% | |
| Total Assets by Business | ||||||
| BSI Bio Spin CALIDNANO And Corporate | $5.98B-1.9% | $6.09B-3.1% | $6.29B+1.5% | $6.19B+7.4% | $5.77B+2.1% | |
| Energy And Supercon Technologies | $194.7M+1.2% | $192.4M+0.6% | $191.3M+0.1% | $191.2M-6.7% | $204.9M+2.6% | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||||||
| Bsi Biospin | $2.4M+118% | $1.1M-77.1% | $4.8M+109% | $2.3M-28.1% | $3.2M-46.7% | |
| Bsi Calid | $6.7M+55.8% | $4.3M-39.4% | $7.1M+29.1% | $5.5M-34.5% | $8.4M-46.8% | |
| Bsi Nano | $4.9M-68.0% | $15.3M+394% | $3.1M-76.5% | $13.2M+169% | $4.9M0.0% | |
| Corporate | $2.3M-20.7% | $2.9M+93.3% | $1.5M-78.3% | $6.9M+46.8% | $4.7M+27.0% | |
| Energy And Supercon Technologies | $1.6M-64.4% | $4.5M+114% | $2.1M-12.5% | $2.4M-50.0% | $4.8M-23.8% | |
| Research And Development Expense by Business | ||||||
| Bsi Biospin | $24.2M-5.8% | $25.7M+12.7% | $22.8M-1.7% | $23.2M+5.5% | $22M-14.1% | |
| Bsi Calid | $33.1M+5.1% | $31.5M+4.0% | $30.3M+1.0% | $30M+7.5% | $27.9M-9.4% | |
| Bsi Nano | $42.9M+3.6% | $41.4M-6.1% | $44.1M-0.7% | $44.4M-2.0% | $45.3M+0.2% | |
| Energy And Supercon Technologies | $800K-20.0% | $1M+42.9% | $700K-36.4% | $1.1M+83.3% | $600K-33.3% | |
| Restructuring And Related Cost Incurred Cost by Business | ||||||
| Bsi Biospin | $3M-63.4% | $8.2M+90.7% | $4.3M— | —— | —— | |
| Bsi Calid | $2M-57.4% | $4.7M-75.5% | $19.2M— | —— | —— | |
| Bsi Nano | -$100K-102% | $5.4M-44.3% | $9.7M— | —— | —— | |
| Corporate | $300K-85.7% | $2.1M+2,200% | -$100K— | —— | —— | |
| Restructuring Charges by Business | ||||||
| Bsi Biospin | $2.9M-17.1% | $3.5M+59.1% | $2.2M+188% | -$2.5M-143% | $5.8M+2,800% | |
| Bsi Calid | $1.5M-60.5% | $3.8M-69.6% | $12.5M+468% | $2.2M+83.3% | $1.2M-14.3% | |
| Bsi Nano | $8.3M+144% | $3.4M-34.6% | $5.2M+44.4% | $3.6M+350% | $800K-42.9% | |
| Corporate | $200K-90.5% | $2.1M+2,200% | -$100K-108% | $1.2M— | $0— | |
| D&A by Business | ||||||
| Bsi Biospin | $11.7M+1.7% | $11.5M+13.9% | $10.1M-9.8% | $11.2M+7.7% | $10.4M-10.3% | |
| Bsi Calid | $24.6M-2.0% | $25.1M+4.6% | $24M+2.6% | $23.4M+18.2% | $19.8M-13.2% | |
| Bsi Nano | $17M+3.0% | $16.5M-2.4% | $16.9M-1.2% | $17.1M+2.4% | $16.7M+10.6% | |
| Corporate | $2.4M-7.7% | $2.6M+18.2% | $2.2M+10.0% | $2M+42.9% | $1.4M0.0% | |
| Energy And Supercon Technologies | $2.6M+8.3% | $2.4M-4.0% | $2.5M+4.2% | $2.4M+14.3% | $2.1M+5.0% | |
| Asset Impairment Charges by Business | ||||||
| Bsi Calid | $2M+233% | $600K-71.4% | $2.1M— | —— | —— | |
| Bsi Nano | $700K— | —— | $16.2M— | —— | —— | |
| Revenue by Product | ||||||
| Product And Service Other | $177M-1.6% | $179.9M+6.2% | $169.4M+4.1% | $162.7M+2.9% | $158.1M-7.5% | |
| Product | $646.4M-18.9% | $797.3M+15.4% | $691.1M+8.9% | $634.7M-1.3% | $643.3M-20.4% | |
| Cost Of Revenue by Product | ||||||
| Product And Service Other | $96M-2.9% | $98.9M+7.4% | $92.1M-1.4% | $93.4M+6.3% | $87.9M-1.0% | |
| Product | $347.6M-19.0% | $429.1M+10.3% | $389M+12.4% | $346.1M+7.4% | $322.3M-18.9% | |
| Revenue by Geography | ||||||
| Asia Pacific Excluding China | $134.7M-17.4% | $163.1M+24.8% | $130.7M+2.6% | $127.4M-3.0% | $131.4M-20.0% | |
| CN | $74M-46.4% | $138.1M+13.4% | $121.8M+6.2% | $114.7M+13.3% | $101.2M-11.1% | |
| DE | $62.7M-40.6% | $105.5M+48.0% | $71.3M+20.6% | $59.1M-3.3% | $61.1M-29.0% | |
| Europe Excluding Germany | $258.9M-4.6% | $271.5M+12.6% | $241.2M+13.0% | $213.4M-4.8% | $224.1M-21.9% | |
| Other Country | $71.2M-3.8% | $74M+6.5% | $69.5M+16.0% | $59.9M-9.5% | $66.2M-1.9% | |
| US | $221.9M-1.4% | $225M-0.4% | $226M+1.4% | $222.9M+2.5% | $217.4M-16.7% | |
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate by Geography | ||||||
| CH | 20%— | —— | —— | —— | 20%— | |
| DE | 30%— | —— | —— | —— | 30%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
